We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEES
3101
DELISTED
H&E Equipment Services
HEES
$244K ﹤0.01%
8,447
-123
-1% -$3.33K
SGOL icon
3102
abrdn Physical Gold Shares ETF
SGOL
$7.49B
$244K ﹤0.01%
17,170
+450
+3% +$6.39K
BFO
3103
DELISTED
Blackrock Florida Municipal 2020 Term Trust
BFO
$244K ﹤0.01%
16,965
-15,300
-47% -$220K
CARO
3104
DELISTED
Carolina Financial Corp.
CARO
$244K ﹤0.01%
6,862
-4,583
-40% -$160K
EVM
3105
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
$243K ﹤0.01%
21,426
+6,453
+43% +$73.1K
EFC
3106
Ellington Financial
EFC
$1.69B
$242K ﹤0.01%
13,399
+36
+0.3% +$639
KGC icon
3107
Kinross Gold
KGC
$32.5B
$242K ﹤0.01%
52,631
-22,027
-30% -$102K
APTS
3108
DELISTED
Preferred Apartment Communities, Inc.
APTS
$242K ﹤0.01%
16,755
-146
-0.9% -$2.1K
ODT
3109
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$242K ﹤0.01%
+9,305
New +$311K
TGP
3110
DELISTED
Teekay LNG Partners L.P.
TGP
$242K ﹤0.01%
17,695
+1,174
+7% +$17.5K
NUM
3111
DELISTED
Nuveen Michigan Quality Municipal Income Fund
NUM
$242K ﹤0.01%
17,365
+187
+1% +$2.62K
MCY icon
3112
Mercury Insurance
MCY
$5.92B
$241K ﹤0.01%
+4,307
New +$246K
RIG icon
3113
Transocean
RIG
$6.33B
$241K ﹤0.01%
53,971
+2,421
+5% +$12.8K
MYC
3114
DELISTED
Blackrock Muni Yield California Fund, Inc.
MYC
$241K ﹤0.01%
16,794
BB icon
3115
BlackBerry
BB
$5.18B
$240K ﹤0.01%
45,765
-3,043
-6% -$21.3K
NG icon
3116
NovaGold Resources
NG
$3.35B
$240K ﹤0.01%
39,516
-11,260
-22% -$73.8K
PRGS icon
3117
Progress Software
PRGS
$1.78B
$240K ﹤0.01%
6,308
-5,700
-47% -$229K
SANM icon
3118
Sanmina
SANM
$10.7B
$240K ﹤0.01%
+7,469
New +$229K
SWBI icon
3119
Smith & Wesson
SWBI
$636M
$240K ﹤0.01%
53,440
+2,024
+4% +$12.2K
MRC
3120
DELISTED
MRC Global
MRC
$239K ﹤0.01%
19,689
-546
-3% -$7.71K
SJR
3121
DELISTED
Shaw Communications Inc.
SJR
$239K ﹤0.01%
12,134
+2,243
+23% +$44.2K
APPS icon
3122
Digital Turbine
APPS
$1.74B
$238K ﹤0.01%
36,945
-8,895
-19% -$55.2K
MAT icon
3123
Mattel
MAT
$4.21B
$238K ﹤0.01%
20,934
-202
-1% -$2.31K
PTCT icon
3124
PTC Therapeutics
PTCT
$6.23B
$238K ﹤0.01%
7,025
-4,197
-37% -$183K
EBIX
3125
DELISTED
Ebix Inc
EBIX
$237K ﹤0.01%
+5,626
New +$236K

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.